# A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis

> **NCT02564042** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 227 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** GSK2894512 1% Cream
- **DRUG:** GSK2894512 0.5% Cream
- **DRUG:** Vehicle cream

## Key facts

- **NCT ID:** NCT02564042
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-23
- **Primary completion:** 2016-10-01
- **Final completion:** 2016-10-05
- **Target enrollment:** 227 (ACTUAL)
- **Last updated:** 2017-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02564042

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02564042, "A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02564042. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*